Impact of the interaction between the polymorphisms and hypermethylation of the CD36 gene on a new biomarker of type 2 diabetes mellitus: circulating soluble CD36 (sCD36) in Senegalese females.

MLA

Touré, Maïmouna, et al. “Impact of the Interaction between the Polymorphisms and Hypermethylation of the CD36 Gene on a New Biomarker of Type 2 Diabetes Mellitus: Circulating Soluble CD36 (SCD36) in Senegalese Females.” BMC Medical Genomics, vol. 15, no. 1, Aug. 2022, p. 186. EBSCOhost, https://doi.org/10.1186/s12920-022-01337-2.

APA

Touré, M., Samb, A., Sène, M., Thiam, S., Mané, C. A. B., Sow, A. K., Ba-Diop, A., Kane, M. O., Sarr, M., Ba, A., & Gueye, L. (2022). Impact of the interaction between the polymorphisms and hypermethylation of the CD36 gene on a new biomarker of type 2 diabetes mellitus: circulating soluble CD36 (sCD36) in Senegalese females. BMC Medical Genomics, 15(1), 186. https://doi.org/10.1186/s12920-022-01337-2

Chicago

Touré, Maïmouna, Abdoulaye Samb, Mbaye Sène, Souleymane Thiam, Cheikh A B Mané, Abdou K Sow, Awa Ba-Diop, et al. 2022. “Impact of the Interaction between the Polymorphisms and Hypermethylation of the CD36 Gene on a New Biomarker of Type 2 Diabetes Mellitus: Circulating Soluble CD36 (SCD36) in Senegalese Females.” BMC Medical Genomics 15 (1): 186. doi:10.1186/s12920-022-01337-2.